Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 12Recruiting 6Terminated 3Active not recruiting 3Unknown 2Withdrawn 1Suspended 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 21Lung Neoplasms 17Neoplasms 7Colorectal Neoplasms 6Uterine Cervical Neoplasms 4Small Cell Lung Carcinoma 4Mesothelioma 4Prostatic Neoplasms 3Ovarian Neoplasms 3Mesothelioma, Malignant 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2NSCLC 2Melanoma 2Endometrial Neoplasms 2Diabetes Mellitus 2Carcinoma, Transitional Cell 2Vulvar Neoplasms 1Uterine Neoplasms 1Thyroid Carcinoma, Anaplastic 1Stomach Neoplasms 1Psoriasis 1Post-Lyme Disease Syndrome 1Pneumonia 1Parkinson Disease 1Pancreatic Neoplasms 1Osteosarcoma 1Obsessive-Compulsive Disorder 1Neoplasms, Squamous Cell 1

Interventions

Prednisone 1Clinical Protocols 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Lung Diseases, Interstitial × Thoracic × Clear all
NCT04036721 2023-02-23

PROS-CONS

National Institute for Tuberculosis and Lung Diseases, Poland

Phase 4 Suspended
85 enrolled
Thoracic

Lung Neoplasms, Pneumonia, Lung Diseases, Interstitial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡